| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | ERVK-6 ERVK-7 ERVK-21 ERVK-9 ERVK-10 SPPL2A ERVK-8 ERVK-18 ERVK-19 ERVK-25 ERVK-24 | 1.74e-14 | 37 | 181 | 11 | GO:0004190 |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | ERVK-6 ERVK-7 ERVK-21 ERVK-9 ERVK-10 SPPL2A ERVK-8 ERVK-18 ERVK-19 ERVK-25 ERVK-24 | 2.43e-14 | 38 | 181 | 11 | GO:0070001 |
| GeneOntologyMolecularFunction | endopeptidase activity | ERVK-6 KLK6 USP9X ERVK-7 ERVK-21 ERVK-9 ERVK-10 ADAM8 SPPL2A MBTPS2 HP ERVK-8 ERVK-18 ERVK-19 ERVK-25 ERVK-24 | 2.02e-06 | 430 | 181 | 16 | GO:0004175 |
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 2.05e-06 | 11 | 181 | 4 | GO:0004523 | |
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 6.09e-06 | 14 | 181 | 4 | GO:0003964 | |
| GeneOntologyMolecularFunction | benzodiazepine receptor binding | 7.23e-06 | 5 | 181 | 3 | GO:0030156 | |
| GeneOntologyMolecularFunction | peptidase activity | ERVK-6 KLK6 USP9X ERVK-7 ERVK-21 ERVK-9 ERVK-10 USP9Y ADAM8 SPPL2A MBTPS2 HP ERVK-8 ERVK-18 ERVK-19 STAMBPL1 ERVK-25 ERVK-24 | 2.93e-05 | 654 | 181 | 18 | GO:0008233 |
| GeneOntologyMolecularFunction | endonuclease activity | 3.42e-05 | 136 | 181 | 8 | GO:0004519 | |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 3.46e-05 | 21 | 181 | 4 | GO:0035613 | |
| GeneOntologyMolecularFunction | P-type calcium transporter activity | 1.15e-04 | 11 | 181 | 3 | GO:0005388 | |
| GeneOntologyMolecularFunction | high voltage-gated calcium channel activity | 2.48e-04 | 14 | 181 | 3 | GO:0008331 | |
| GeneOntologyMolecularFunction | nuclease activity | 2.67e-04 | 231 | 181 | 9 | GO:0004518 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity, producing 5'-phosphomonoesters | 3.41e-04 | 37 | 181 | 4 | GO:0016891 | |
| GeneOntologyMolecularFunction | DNA polymerase activity | 3.79e-04 | 38 | 181 | 4 | GO:0034061 | |
| GeneOntologyMolecularFunction | calcium-dependent ATPase activity | 4.84e-04 | 4 | 181 | 2 | GO:0030899 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity | 7.59e-04 | 79 | 181 | 5 | GO:0004521 | |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 7.92e-04 | 46 | 181 | 4 | GO:0016893 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in cardiac muscle cell action potential | 8.03e-04 | 5 | 181 | 2 | GO:0086007 | |
| GeneOntologyMolecularFunction | cytoskeleton-nuclear membrane anchor activity | 8.03e-04 | 5 | 181 | 2 | GO:0140444 | |
| GeneOntologyMolecularFunction | enzyme activator activity | EPO EED APOA5 TBC1D2 CDC20B RGS7 NF1 ARAP3 PSME4 UBE2L3 ATP2A3 CDK5R2 ARAP1 ARAP2 WDR48 | 9.66e-04 | 656 | 181 | 15 | GO:0008047 |
| GeneOntologyMolecularFunction | phosphatidylinositol-3,4,5-trisphosphate binding | 1.01e-03 | 49 | 181 | 4 | GO:0005547 | |
| GeneOntologyMolecularFunction | enzyme regulator activity | EPO EED NLRP7 KALRN APOA5 CYTH3 TBC1D2 CDC20B PLEKHG2 RGS7 FAF1 NF1 ARAP3 PSME4 UBE2L3 PPP1R15B CST2 KNDC1 TNK2 HERC2 ATP2A3 CDK5R2 ARAP1 ARAP2 WDR48 | 1.05e-03 | 1418 | 181 | 25 | GO:0030234 |
| GeneOntologyMolecularFunction | zinc ion binding | ERVK-6 KDM4C ERVK-7 ERVK-21 ERVK-9 ERVK-10 ADAM8 TRIP12 TRAFD1 RTL3 SLFN13 ERVK-8 ERVK-5 ZFHX2 ERVK-19 HERC2 DMD ERVK-24 | 1.26e-03 | 891 | 181 | 18 | GO:0008270 |
| GeneOntologyMolecularFunction | RNA nuclease activity | 1.52e-03 | 136 | 181 | 6 | GO:0004540 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | KALRN CYTH3 TBC1D2 PLEKHG2 RGS7 NF1 ARAP3 KNDC1 TNK2 HERC2 ARAP1 ARAP2 | 2.33e-03 | 507 | 181 | 12 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | KALRN CYTH3 TBC1D2 PLEKHG2 RGS7 NF1 ARAP3 KNDC1 TNK2 HERC2 ARAP1 ARAP2 | 2.33e-03 | 507 | 181 | 12 | GO:0030695 |
| GeneOntologyBiologicalProcess | DNA integration | 3.94e-06 | 13 | 182 | 4 | GO:0015074 | |
| GeneOntologyBiologicalProcess | cell-cell fusion | 1.03e-05 | 85 | 182 | 7 | GO:0140253 | |
| GeneOntologyBiologicalProcess | syncytium formation by plasma membrane fusion | 1.03e-05 | 85 | 182 | 7 | GO:0000768 | |
| GeneOntologyBiologicalProcess | syncytium formation | 1.39e-05 | 89 | 182 | 7 | GO:0006949 | |
| GeneOntologyBiologicalProcess | calcium ion transport from cytosol to endoplasmic reticulum | 7.74e-05 | 2 | 182 | 2 | GO:1903515 | |
| GeneOntologyCellularComponent | platelet dense tubular network membrane | 5.33e-05 | 9 | 183 | 3 | GO:0031095 | |
| GeneOntologyCellularComponent | H zone | 7.62e-05 | 2 | 183 | 2 | GO:0031673 | |
| GeneOntologyCellularComponent | manchette | 9.87e-05 | 28 | 183 | 4 | GO:0002177 | |
| GeneOntologyCellularComponent | platelet dense tubular network | 1.03e-04 | 11 | 183 | 3 | GO:0031094 | |
| GeneOntologyCellularComponent | presynapse | CACNA1C CACNA1D KALRN WDR7 AAK1 ITGA3 ZDHHC17 GABBR2 RGS7 MYOF NF1 VPS33B UBE2L3 TNK2 DMD FBXL20 MCTP2 CDK5R2 CNTN1 | 2.96e-04 | 886 | 183 | 19 | GO:0098793 |
| MousePheno | abnormal synapse morphology | CACNA1F NES KALRN SYNE1 ZDHHC17 GABBR2 DST SYNE2 NEMF KNDC1 DMD DYNC1H1 | 1.89e-06 | 224 | 136 | 12 | MP:0009538 |
| MousePheno | abnormal neuromuscular synapse morphology | 3.83e-05 | 95 | 136 | 7 | MP:0001053 | |
| MousePheno | abnormal somatic motor system morphology | 4.68e-05 | 98 | 136 | 7 | MP:0001051 | |
| MousePheno | axonal dystrophy | 5.47e-05 | 22 | 136 | 4 | MP:0003225 | |
| Domain | Spectrin | 1.66e-11 | 23 | 169 | 8 | PF00435 | |
| Domain | Spectrin_repeat | 1.39e-10 | 29 | 169 | 8 | IPR002017 | |
| Domain | SPEC | 3.33e-10 | 32 | 169 | 8 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 3.33e-10 | 32 | 169 | 8 | IPR018159 | |
| Domain | ACTININ_2 | 9.51e-10 | 23 | 169 | 7 | PS00020 | |
| Domain | ACTININ_1 | 9.51e-10 | 23 | 169 | 7 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 9.51e-10 | 23 | 169 | 7 | IPR001589 | |
| Domain | WD_REPEATS_1 | DCAF1 NWD1 EED WDR64 WDR7 CORO1C CDC20B EDC4 TECPR2 WDCP CORO6 WDR12 HERC2 WDR44 WDR48 | 3.64e-08 | 278 | 169 | 15 | PS00678 |
| Domain | WD_REPEATS_2 | DCAF1 NWD1 EED WDR64 WDR7 CORO1C CDC20B EDC4 TECPR2 WDCP CORO6 WDR12 HERC2 WDR44 WDR48 | 3.82e-08 | 279 | 169 | 15 | PS50082 |
| Domain | WD_REPEATS_REGION | DCAF1 NWD1 EED WDR64 WDR7 CORO1C CDC20B EDC4 TECPR2 WDCP CORO6 WDR12 HERC2 WDR44 WDR48 | 3.82e-08 | 279 | 169 | 15 | PS50294 |
| Domain | WD40_repeat_dom | DCAF1 NWD1 EED WDR64 WDR7 CORO1C CDC20B LRRK1 EDC4 TECPR2 CORO6 WDR12 WDR44 WDR48 | 5.48e-07 | 297 | 169 | 14 | IPR017986 |
| Domain | CAC1F_C | 7.28e-07 | 3 | 169 | 3 | IPR031688 | |
| Domain | CAC1F_C | 7.28e-07 | 3 | 169 | 3 | PF16885 | |
| Domain | P-type_ATPase_IIA | 7.28e-07 | 3 | 169 | 3 | IPR005782 | |
| Domain | WD40_repeat | NWD1 EED WDR64 WDR7 CORO1C CDC20B EDC4 TECPR2 CORO6 WDR12 HERC2 WDR44 WDR48 | 1.21e-06 | 272 | 169 | 13 | IPR001680 |
| Domain | CH | 1.96e-06 | 65 | 169 | 7 | SM00033 | |
| Domain | - | DCAF1 NWD1 EED WDR64 WDR7 CORO1C CDC20B EDC4 TECPR2 WDCP CORO6 WDR12 WDR44 WDR48 | 2.13e-06 | 333 | 169 | 14 | 2.130.10.10 |
| Domain | WD40/YVTN_repeat-like_dom | DCAF1 NWD1 EED WDR64 WDR7 CORO1C CDC20B EDC4 TECPR2 WDCP CORO6 WDR12 WDR44 WDR48 | 2.28e-06 | 335 | 169 | 14 | IPR015943 |
| Domain | VDCC_L_a1su | 2.89e-06 | 4 | 169 | 3 | IPR005446 | |
| Domain | CH | 3.26e-06 | 70 | 169 | 7 | PF00307 | |
| Domain | - | 3.58e-06 | 71 | 169 | 7 | 1.10.418.10 | |
| Domain | CH | 4.33e-06 | 73 | 169 | 7 | PS50021 | |
| Domain | CH-domain | 5.19e-06 | 75 | 169 | 7 | IPR001715 | |
| Domain | WD40 | NWD1 EED WDR64 WDR7 CORO1C CDC20B EDC4 TECPR2 CORO6 WDR12 WDR44 WDR48 | 6.16e-06 | 268 | 169 | 12 | SM00320 |
| Domain | - | 1.43e-05 | 6 | 169 | 3 | 3.90.1290.10 | |
| Domain | Plectin | 2.48e-05 | 7 | 169 | 3 | PF00681 | |
| Domain | Ca_chan_IQ | 2.48e-05 | 7 | 169 | 3 | SM01062 | |
| Domain | Ca_chan_IQ | 2.48e-05 | 7 | 169 | 3 | PF08763 | |
| Domain | Plectin_repeat | 2.48e-05 | 7 | 169 | 3 | IPR001101 | |
| Domain | VDCC_a1su_IQ | 2.48e-05 | 7 | 169 | 3 | IPR014873 | |
| Domain | GPHH | 2.48e-05 | 7 | 169 | 3 | PF16905 | |
| Domain | GPHH_dom | 2.48e-05 | 7 | 169 | 3 | IPR031649 | |
| Domain | PLEC | 2.48e-05 | 7 | 169 | 3 | SM00250 | |
| Domain | - | LRRC66 LRRC75B NLRP7 LRRTM3 LRRK1 TLR8 FBXL3 FBXL6 IGFALS NLRC5 FBXL20 DRC3 | 3.70e-05 | 321 | 169 | 12 | 3.80.10.10 |
| Domain | L_dom-like | LRRC66 LRRC75B NLRP7 LRRTM3 LRRK1 TLR8 FBXL3 FBXL6 IGFALS NLRC5 FBXL20 DRC3 | 4.56e-05 | 328 | 169 | 12 | IPR032675 |
| Domain | PH | KALRN CYTH3 TBC1D2 PLEKHG2 SPTBN4 SPTBN5 ARAP3 PLCH2 ARAP1 ARAP2 | 4.61e-05 | 229 | 169 | 10 | PF00169 |
| Domain | - | 8.14e-05 | 2 | 169 | 2 | 1.25.40.170 | |
| Domain | PHAT_dom | 8.14e-05 | 2 | 169 | 2 | IPR015327 | |
| Domain | Hydrolase_3 | 8.34e-05 | 10 | 169 | 3 | PF08282 | |
| Domain | VDCCAlpha1 | 8.34e-05 | 10 | 169 | 3 | IPR002077 | |
| Domain | HECT | 9.65e-05 | 27 | 169 | 4 | PF00632 | |
| Domain | HECTc | 9.65e-05 | 27 | 169 | 4 | SM00119 | |
| Domain | HECT_dom | 9.65e-05 | 27 | 169 | 4 | IPR000569 | |
| Domain | HECT | 9.65e-05 | 27 | 169 | 4 | PS50237 | |
| Domain | WD40_repeat_CS | 1.26e-04 | 164 | 169 | 8 | IPR019775 | |
| Domain | WD40 | 1.28e-04 | 259 | 169 | 10 | PF00400 | |
| Domain | LRR_1 | 1.76e-04 | 219 | 169 | 9 | PF00560 | |
| Domain | Leu-rich_rpt | LRRC66 LRRC75B LRRTM3 LRRK1 TLR8 FBXL6 IGFALS NLRC5 FBXL20 DRC3 | 1.85e-04 | 271 | 169 | 10 | IPR001611 |
| Domain | PH | KALRN CYTH3 TBC1D2 PLEKHG2 SPTBN4 SPTBN5 ARAP3 PLCH2 ARAP1 ARAP2 | 2.27e-04 | 278 | 169 | 10 | SM00233 |
| Domain | PH_DOMAIN | KALRN CYTH3 TBC1D2 PLEKHG2 SPTBN4 SPTBN5 ARAP3 PLCH2 ARAP1 ARAP2 | 2.34e-04 | 279 | 169 | 10 | PS50003 |
| Domain | PH_domain | KALRN CYTH3 TBC1D2 PLEKHG2 SPTBN4 SPTBN5 ARAP3 PLCH2 ARAP1 ARAP2 | 2.41e-04 | 280 | 169 | 10 | IPR001849 |
| Domain | TECPR | 2.43e-04 | 3 | 169 | 2 | SM00706 | |
| Domain | Beta-propeller_rpt_TECPR | 2.43e-04 | 3 | 169 | 2 | IPR006624 | |
| Domain | RA | 3.04e-04 | 36 | 169 | 4 | PF00788 | |
| Domain | RA | 3.38e-04 | 37 | 169 | 4 | PS50200 | |
| Domain | ATPase_P-typ_TM_dom | 3.74e-04 | 16 | 169 | 3 | IPR023298 | |
| Domain | - | 3.74e-04 | 16 | 169 | 3 | 1.20.1110.10 | |
| Domain | ATPase_P-typ_cation-transptr_C | 4.51e-04 | 17 | 169 | 3 | IPR006068 | |
| Domain | Cation_ATPase_C | 4.51e-04 | 17 | 169 | 3 | PF00689 | |
| Domain | RA_dom | 4.59e-04 | 40 | 169 | 4 | IPR000159 | |
| Domain | KASH | 4.83e-04 | 4 | 169 | 2 | IPR012315 | |
| Domain | KASH | 4.83e-04 | 4 | 169 | 2 | PS51049 | |
| Domain | KASH | 4.83e-04 | 4 | 169 | 2 | SM01249 | |
| Domain | KASH | 4.83e-04 | 4 | 169 | 2 | PF10541 | |
| Domain | Cation_ATPase_N | 5.37e-04 | 18 | 169 | 3 | PF00690 | |
| Domain | Cation_ATPase_N | 5.37e-04 | 18 | 169 | 3 | SM00831 | |
| Domain | Leu-rich_rpt_Cys-con_subtyp | 6.34e-04 | 19 | 169 | 3 | IPR006553 | |
| Domain | LRR_CC | 6.34e-04 | 19 | 169 | 3 | SM00367 | |
| Domain | ATPase_P-typ_cation-transptr_N | 6.34e-04 | 19 | 169 | 3 | IPR004014 | |
| Domain | SH3 | 7.99e-04 | 216 | 169 | 8 | PS50002 | |
| Domain | Ammonium_transpt | 8.00e-04 | 5 | 169 | 2 | IPR001905 | |
| Domain | Ammonium_transp | 8.00e-04 | 5 | 169 | 2 | PF00909 | |
| Domain | NH4_transpt_AmtB-like_dom | 8.00e-04 | 5 | 169 | 2 | IPR024041 | |
| Domain | RhesusRHD | 8.00e-04 | 5 | 169 | 2 | IPR002229 | |
| Domain | SH3_domain | 9.00e-04 | 220 | 169 | 8 | IPR001452 | |
| Domain | zf-CCHC | 1.13e-03 | 23 | 169 | 3 | PF00098 | |
| Domain | GAR | 1.19e-03 | 6 | 169 | 2 | PS51460 | |
| Domain | GAS2 | 1.19e-03 | 6 | 169 | 2 | PF02187 | |
| Domain | - | 1.19e-03 | 6 | 169 | 2 | 3.30.920.20 | |
| Domain | GAS_dom | 1.19e-03 | 6 | 169 | 2 | IPR003108 | |
| Domain | GAS2 | 1.19e-03 | 6 | 169 | 2 | SM00243 | |
| Domain | SAM | 1.22e-03 | 88 | 169 | 5 | SM00454 | |
| Domain | C2 | 1.24e-03 | 131 | 169 | 6 | PF00168 | |
| Domain | C2 | 1.55e-03 | 137 | 169 | 6 | SM00239 | |
| Domain | Trimer_CC | 1.66e-03 | 7 | 169 | 2 | IPR015049 | |
| Domain | DUF1899 | 1.66e-03 | 7 | 169 | 2 | IPR015048 | |
| Domain | Trimer_CC | 1.66e-03 | 7 | 169 | 2 | PF08954 | |
| Domain | DUF1899 | 1.66e-03 | 7 | 169 | 2 | PF08953 | |
| Domain | Coronin | 1.66e-03 | 7 | 169 | 2 | IPR015505 | |
| Domain | - | 1.66e-03 | 7 | 169 | 2 | 1.10.3430.10 | |
| Domain | Ammonium/urea_transptr | 1.66e-03 | 7 | 169 | 2 | IPR029020 | |
| Domain | DUF1899 | 1.66e-03 | 7 | 169 | 2 | SM01166 | |
| Domain | SAM_DOMAIN | 1.72e-03 | 95 | 169 | 5 | PS50105 | |
| Domain | PH_dom-like | KALRN CYTH3 TBC1D2 VPS36 PLEKHG2 SPTBN4 SPTBN5 ARAP3 PLCH2 ARAP1 ARAP2 | 1.76e-03 | 426 | 169 | 11 | IPR011993 |
| Domain | C2 | 1.87e-03 | 142 | 169 | 6 | PS50004 | |
| Domain | SAM | 1.88e-03 | 97 | 169 | 5 | IPR001660 | |
| Domain | ArfGap | 2.24e-03 | 29 | 169 | 3 | SM00105 | |
| Domain | ARFGAP | 2.24e-03 | 29 | 169 | 3 | PS50115 | |
| Domain | ArfGap | 2.24e-03 | 29 | 169 | 3 | PF01412 | |
| Domain | ArfGAP | 2.24e-03 | 29 | 169 | 3 | IPR001164 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_VGCC_CA2_APOPTOTIC_PATHWAY | 1.27e-05 | 6 | 123 | 3 | M47762 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_SERCA | 3.52e-05 | 8 | 123 | 3 | M47955 | |
| Pathway | KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC | 4.46e-05 | 74 | 123 | 6 | M16376 | |
| Pathway | WP_ALZHEIMERS_DISEASE | 4.46e-05 | 74 | 123 | 6 | MM15962 | |
| Pathway | WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY | 4.46e-05 | 74 | 123 | 6 | M39462 | |
| Pathway | KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM | 8.52e-05 | 83 | 123 | 6 | M8728 | |
| Pathway | KEGG_DILATED_CARDIOMYOPATHY | 1.34e-04 | 90 | 123 | 6 | M835 | |
| Pathway | REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS | 1.35e-04 | 12 | 123 | 3 | M27326 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 2.19e-04 | 63 | 123 | 5 | M11187 | |
| Pathway | REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS | 2.20e-04 | 14 | 123 | 3 | MM15052 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_VGCC_CA2_APOPTOTIC_PATHWAY_N01004 | 2.20e-04 | 14 | 123 | 3 | M47692 | |
| Pathway | BIOCARTA_ARAP_PATHWAY | 4.03e-04 | 17 | 123 | 3 | M2482 | |
| Pubmed | A revised nomenclature for transcribed human endogenous retroviral loci. | ERVK-6 ERVK-7 ERVK-21 ERVK-9 ERVK-10 ERVK-8 ERVK-18 ERVK-5 ERVK-19 ERVK-25 ERVK-24 | 3.17e-12 | 94 | 184 | 11 | 21542922 |
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 3.92e-12 | 5 | 184 | 5 | 12629516 | |
| Pubmed | 3.56e-10 | 18 | 184 | 6 | 18664271 | ||
| Pubmed | Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. | 7.58e-10 | 4 | 184 | 4 | 10469592 | |
| Pubmed | 7.58e-10 | 4 | 184 | 4 | 7983737 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ENGASE EPPK1 KALRN CYTH3 AOC2 LRRK1 ITGA3 EDC4 FAAP100 TNFRSF21 MYOF DST ARAP3 PSME4 PPP1R15B NLRC5 TNK2 FGFR1 ULK1 HERC2 SNAPC4 ATP2A3 SMURF2 DYNC1H1 ARAP1 | 1.08e-09 | 1105 | 184 | 25 | 35748872 |
| Pubmed | 3.02e-09 | 12 | 184 | 5 | 14557543 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | CACNA1C AIMP2 MAP1B VPS13C WWP2 SAMD4B AAK1 LMBR1 PORCN RILPL1 STEAP2 FAF1 SPTBN4 DNAAF5 DFFB ESYT2 TECPR2 NEMF KNDC1 NLRC5 ZFHX2 MACF1 TNK2 MCTP2 SMURF2 TMEM181 ARAP1 | 2.40e-08 | 1489 | 184 | 27 | 28611215 |
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 4.85e-08 | 38 | 184 | 6 | 30786075 | |
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 10516026 | ||
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 16410239 | ||
| Pubmed | Activation of E3 ubiquitin ligase WWP2 by non-receptor tyrosine kinase ACK1. | 1.46e-07 | 3 | 184 | 3 | 36773333 | |
| Pubmed | 5.80e-07 | 4 | 184 | 3 | 20937870 | ||
| Pubmed | 5.80e-07 | 4 | 184 | 3 | 25110346 | ||
| Pubmed | The nongastric H+-K+-ATPases: molecular and functional properties. | 5.80e-07 | 4 | 184 | 3 | 10362770 | |
| Pubmed | 5.80e-07 | 4 | 184 | 3 | 8954775 | ||
| Pubmed | RIM-BP3 is a manchette-associated protein essential for spermiogenesis. | 5.80e-07 | 4 | 184 | 3 | 19091768 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | KIFBP EMC1 CMTM4 USP9X PEX1 LMBR1 EDC4 ZDHHC17 TRIP12 RNF126 FAF1 MED24 DNAAF5 ESYT2 PDE12 TRAFD1 DDRGK1 ATP2A2 DYNC1H1 | 7.07e-07 | 942 | 184 | 19 | 31073040 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | NES EMC1 MAP1B NELFCD WWP2 SAMD4B AAK1 PLEKHG2 EDC4 TRIP12 ESYT2 DST NF1 MAP4K1 SYNE2 MACF1 ARAP2 SAMD4A | 8.49e-07 | 861 | 184 | 18 | 36931259 |
| Pubmed | NES KIFBP KALRN WDR7 USP9X CYTH3 SYNE1 CORO1C AAK1 EDC4 GABBR2 SPTBN4 DST NF1 SYNE2 MACF1 HERC2 DYNC1H1 CNTN1 | 9.81e-07 | 963 | 184 | 19 | 28671696 | |
| Pubmed | 1.17e-06 | 101 | 184 | 7 | 9872452 | ||
| Pubmed | KALRN KDM4C USP9X CYTH3 SYNE1 CORO1C RILPL1 USP9Y TRIP12 TDP2 STAT1 FAF1 SPTBN4 HEATR6 DST NEMF MACF1 STAMBPL1 HERC2 ATP2A2 SMURF2 DYNC1H1 | 1.38e-06 | 1285 | 184 | 22 | 35914814 | |
| Pubmed | Transcriptionally active HERV-K genes: identification, isolation, and chromosomal mapping. | 1.45e-06 | 5 | 184 | 3 | 11401426 | |
| Pubmed | Structure and evolution of RIM-BP genes: identification of a novel family member. | 1.45e-06 | 5 | 184 | 3 | 17855024 | |
| Pubmed | DCAF1 WDR7 SYNE1 ZDHHC17 PACS2 MACF1 PPIP5K1 ULK1 TMEM181 DYNC1H1 ARAP2 WDR48 | 2.01e-06 | 407 | 184 | 12 | 12693553 | |
| Pubmed | 2.88e-06 | 6 | 184 | 3 | 15063128 | ||
| Pubmed | 2.88e-06 | 6 | 184 | 3 | 11804589 | ||
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | EPO KIFBP EPPK1 EMC1 NELFCD USP9X SAMD4B LRRK1 STAT1 DNAAF5 DFFB UBE2L3 WDCP DDRGK1 CLEC3B ULK1 HERC2 ATP2A2 ATP2A3 DYNC1H1 SAMD4A | 4.95e-06 | 1284 | 184 | 21 | 17353931 |
| Pubmed | Ebf factors and MyoD cooperate to regulate muscle relaxation via Atp2a1. | 5.02e-06 | 7 | 184 | 3 | 24786561 | |
| Pubmed | 5.02e-06 | 7 | 184 | 3 | 12900400 | ||
| Pubmed | 5.02e-06 | 7 | 184 | 3 | 20978237 | ||
| Pubmed | 5.15e-06 | 22 | 184 | 4 | 28890335 | ||
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | 7.27e-06 | 313 | 184 | 10 | 38270169 | |
| Pubmed | Autoinhibition of the HECT-type ubiquitin ligase Smurf2 through its C2 domain. | 8.00e-06 | 8 | 184 | 3 | 17719543 | |
| Pubmed | 8.00e-06 | 8 | 184 | 3 | 11784029 | ||
| Pubmed | 8.00e-06 | 8 | 184 | 3 | 10951186 | ||
| Pubmed | Roles of IP3R and RyR Ca2+ channels in endoplasmic reticulum stress and beta-cell death. | 8.00e-06 | 8 | 184 | 3 | 19033399 | |
| Pubmed | Widespread control of calcium signaling by a family of SERCA-inhibiting micropeptides. | 8.00e-06 | 8 | 184 | 3 | 27923914 | |
| Pubmed | System-Wide Modulation of HECT E3 Ligases with Selective Ubiquitin Variant Probes. | 1.03e-05 | 26 | 184 | 4 | 26949039 | |
| Pubmed | NES EPPK1 MAP1B USP9X EDC4 TRIP12 DST NF1 SYNE2 MACF1 WDR12 HERC2 ATP2A2 DYNC1H1 | 1.11e-05 | 653 | 184 | 14 | 22586326 | |
| Pubmed | A micropeptide encoded by a putative long noncoding RNA regulates muscle performance. | 1.20e-05 | 9 | 184 | 3 | 25640239 | |
| Pubmed | 1.33e-05 | 266 | 184 | 9 | 19380743 | ||
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | NES MAP1B USP9X CORO1C AAK1 EDC4 TRIP12 STAT1 PDE12 DST SYNE2 MACF1 | 1.54e-05 | 498 | 184 | 12 | 36634849 |
| Pubmed | 1.70e-05 | 10 | 184 | 3 | 12970426 | ||
| Pubmed | 1.70e-05 | 10 | 184 | 3 | 9384609 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | GCFC2 SAMD4B TBC1D2 AAK1 TRIP12 MED24 MYOF ESYT2 TRAFD1 NF1 MAP4K1 PACS2 SNAPC4 ATP2A2 WDR44 | 1.76e-05 | 774 | 184 | 15 | 15302935 |
| Pubmed | DCAF1 KIFBP EMC1 NELFCD TRIP12 STAT1 NDUFS5 ESYT2 PDE12 TRAFD1 TAMM41 UBE2L3 DDRGK1 DYNC1H1 | 1.92e-05 | 686 | 184 | 14 | 28380382 | |
| Pubmed | [Genetic predisposition to development of toxic liver cirrhosis caused by alcohol]. | 2.33e-05 | 11 | 184 | 3 | 11436564 | |
| Pubmed | 2.33e-05 | 11 | 184 | 3 | 17996703 | ||
| Pubmed | 2.33e-05 | 11 | 184 | 3 | 18809727 | ||
| Pubmed | 2.33e-05 | 11 | 184 | 3 | 26609159 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 8188244 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 12556521 | ||
| Pubmed | DCS-1, DCS-2, and DFV share amino acid substitutions at the extracellular RhD protein vestibule. | 2.78e-05 | 2 | 184 | 2 | 17900276 | |
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 32697929 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 11792814 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 11002341 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 23583712 | ||
| Pubmed | Review: the molecular basis of the Rh blood group phenotypes. | 2.78e-05 | 2 | 184 | 2 | 15373666 | |
| Pubmed | Nesprin-1 and nesprin-2 regulate endothelial cell shape and migration. | 2.78e-05 | 2 | 184 | 2 | 24931616 | |
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 21054386 | ||
| Pubmed | Intron 4 of the RH Gene in Han Chinese, Tibetan, and Mongol Populations. | 2.78e-05 | 2 | 184 | 2 | 26579938 | |
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 19644701 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 23016887 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 34968422 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 1898705 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 11161244 | ||
| Pubmed | RH diversity in Mali: characterization of a new haplotype RHD*DIVa/RHCE*ceTI(D2). | 2.78e-05 | 2 | 184 | 2 | 25857637 | |
| Pubmed | Sarco(endo)plasmic reticulum Ca2+ ATPases (SERCA1 and -2) in human extraocular muscles. | 2.78e-05 | 2 | 184 | 2 | 14638697 | |
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 22738288 | ||
| Pubmed | Multiple Rh messenger RNA isoforms are produced by alternative splicing. | 2.78e-05 | 2 | 184 | 2 | 1379850 | |
| Pubmed | Voltage-Gated Cav1 Channels in Disorders of Vision and Hearing. | 2.78e-05 | 2 | 184 | 2 | 25966695 | |
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 10329015 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 24086669 | ||
| Pubmed | Microtubule stability, Golgi organization, and transport flux require dystonin-a2-MAP1B interaction. | 2.78e-05 | 2 | 184 | 2 | 22412020 | |
| Pubmed | Ubiquitin-specific protease activity of USP9Y, a male infertility gene on the Y chromosome. | 2.78e-05 | 2 | 184 | 2 | 12895410 | |
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 19650915 | ||
| Pubmed | Differential zinc permeation and blockade of L-type Ca2+ channel isoforms Cav1.2 and Cav1.3. | 2.78e-05 | 2 | 184 | 2 | 26049024 | |
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 19225208 | ||
| Pubmed | Ca1.2 and CaV1.3 neuronal L-type calcium channels: differential targeting and signaling to pCREB. | 2.78e-05 | 2 | 184 | 2 | 16706838 | |
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 23772606 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 23761887 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 14981074 | ||
| Pubmed | CaV1.2 and CaV1.3 channel hyperactivation in mouse islet β cells exposed to type 1 diabetic serum. | 2.78e-05 | 2 | 184 | 2 | 25292336 | |
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 3135863 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 17526649 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 12606379 | ||
| Pubmed | Pyrimidine-2,4,6-triones are a new class of voltage-gated L-type Ca2+ channel activators. | 2.78e-05 | 2 | 184 | 2 | 24941892 | |
| Pubmed | Sequences and evolution of mammalian RH gene transcripts and proteins. | 2.78e-05 | 2 | 184 | 2 | 9811965 | |
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 19962989 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 12393640 | ||
| Pubmed | Molecular genetic basis of the human Rhesus blood group system. | 2.78e-05 | 2 | 184 | 2 | 8220426 | |
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 22826131 | ||
| Pubmed | C-terminal modulator controls Ca2+-dependent gating of Ca(v)1.4 L-type Ca2+ channels. | 2.78e-05 | 2 | 184 | 2 | 16921373 | |
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 24470632 | ||
| Pubmed | Isolation of a new cDNA clone encoding an Rh polypeptide associated with the Rh blood group system. | 2.78e-05 | 2 | 184 | 2 | 7916743 | |
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 8922996 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 22690701 | ||
| Pubmed | No Distinction of Orthology/Paralogy between Human and Chimpanzee Rh Blood Group Genes. | 2.78e-05 | 2 | 184 | 2 | 26872772 | |
| Pubmed | RHCE*ceTI encodes partial c and partial e and is often in cis to RHD*DIVa. | 2.78e-05 | 2 | 184 | 2 | 22804620 | |
| Interaction | NBR1 interactions | EED EPPK1 MAP1B IRF3 E2F2 DNAAF5 MYOF DST MACF1 TNK2 CORO6 ULK1 SNAPC4 DYNC1H1 | 4.12e-06 | 380 | 169 | 14 | int:NBR1 |
| Cytoband | 22q11.21 | 8.68e-05 | 111 | 183 | 5 | 22q11.21 | |
| GeneFamily | WD repeat domain containing | 5.32e-06 | 262 | 112 | 10 | 362 | |
| GeneFamily | EF-hand domain containing|Plakins | 1.27e-05 | 8 | 112 | 3 | 939 | |
| GeneFamily | ATPases Ca2+ transporting | 1.89e-05 | 9 | 112 | 3 | 1209 | |
| GeneFamily | Sterile alpha motif domain containing | 2.17e-04 | 88 | 112 | 5 | 760 | |
| GeneFamily | Spectrin repeat containing nuclear envelope family | 2.26e-04 | 4 | 112 | 2 | 1252 | |
| GeneFamily | F-box and leucine rich repeat proteins | 2.84e-04 | 21 | 112 | 3 | 558 | |
| GeneFamily | Calcium voltage-gated channel subunits | 5.42e-04 | 26 | 112 | 3 | 253 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 7.71e-04 | 394 | 112 | 9 | 471 | |
| GeneFamily | WD repeat domain containing|Coronins | 7.83e-04 | 7 | 112 | 2 | 495 | |
| GeneFamily | EF-hand domain containing|Spectrins | 7.83e-04 | 7 | 112 | 2 | 1113 | |
| GeneFamily | ArfGAPs | 1.10e-03 | 33 | 112 | 3 | 395 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.79e-03 | 206 | 112 | 6 | 682 | |
| GeneFamily | CD molecules|Integrin alpha subunits | 5.45e-03 | 18 | 112 | 2 | 1160 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 5.45e-03 | 18 | 112 | 2 | 91 | |
| ToppCell | mild-low-quality_cells|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | LRRC66 RSPH4A SYNE1 AAK1 USP9Y SLFN13 SYNE2 NLRC5 MCTP2 TMEM181 ARAP2 | 3.48e-10 | 197 | 173 | 11 | e4331969bd911d1ebb5453f40a7057297b5389b4 |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | CACNA1C CACNA1D MAP1B KALRN SYNE1 AAK1 GABBR2 RGS7 SPTBN4 CORO6 CNTN1 | 4.08e-10 | 200 | 173 | 11 | 48d801219bc771d6c7e151dc88ca4c179988de85 |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | CACNA1C CACNA1D MAP1B KALRN SYNE1 GABBR2 RGS7 SPTBN4 CORO6 CNTN1 | 5.37e-09 | 196 | 173 | 10 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | CACNA1C CACNA1D MAP1B KALRN SYNE1 GABBR2 RGS7 SPTBN4 CORO6 CNTN1 | 5.91e-09 | 198 | 173 | 10 | c01091ef18e096d792ea2a7a715764a5b215355f |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | CACNA1C CACNA1D MAP1B KALRN SYNE1 GABBR2 RGS7 SPTBN4 CORO6 CNTN1 | 5.91e-09 | 198 | 173 | 10 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 |
| ToppCell | COVID-19-Endothelial_cells-Capillary_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 3.97e-08 | 181 | 173 | 9 | c5f9c92af1384d9089c65afdf41c6feb8345a3ae | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell-NK_CD56bright|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.31e-08 | 191 | 173 | 9 | f1935e8f8467a2bc30588b7f2cc3b94e9c83b268 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell-NK_CD56bright-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.31e-08 | 191 | 173 | 9 | 1161e465c50c2071764279e01cf08b1048cce0e3 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell-NK_CD56bright-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.31e-08 | 191 | 173 | 9 | 7a4fe96989f72159385270c712342ba3e1ca6fc3 | |
| ToppCell | Control-Lymphoid_T/NK-NK_CD56bright|Control / Disease group, lineage and cell class | 6.31e-08 | 191 | 173 | 9 | e842f29bc03ed6734b2a7b975e7830a498f2743c | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell-NK_CD56bright|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.31e-08 | 191 | 173 | 9 | c023ca893ceae19b54967096f6e2588dc39fa268 | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.89e-08 | 193 | 173 | 9 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.53e-08 | 195 | 173 | 9 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.53e-08 | 195 | 173 | 9 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.58e-08 | 198 | 173 | 9 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.58e-08 | 198 | 173 | 9 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.96e-08 | 199 | 173 | 9 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | 367C-Lymphocytic-ILC-ILC-3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.31e-07 | 161 | 173 | 8 | 8de421c61f4d5a6e05fdb20e4d230e2db98ee4d5 | |
| ToppCell | normal-na-Lymphocytic_NK-NK_bright-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 2.66e-07 | 164 | 173 | 8 | b5a91f2cbfad9a2bc38aea576085a37865df955d | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.18e-07 | 174 | 173 | 8 | f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.97e-07 | 178 | 173 | 8 | fcbbcc44271515de1969b4732b6441c012693d5f | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.51e-07 | 188 | 173 | 8 | a91443aa8fa8fa87f7501c59219daa0305bd0bbf | |
| ToppCell | (210)_NKT_cell|World / immune cells in Peripheral Blood (logTPM normalization) | 8.80e-07 | 192 | 173 | 8 | 08dc0c019c594da7b9944db8fd706aa7780e6ae9 | |
| ToppCell | (21)_NKT_cell|World / immune cells in Peripheral Blood (logTPM normalization) | 8.80e-07 | 192 | 173 | 8 | b0a573ddde2978485a857b8261ee1ee5ef68ecef | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-bulge_keratinocyte|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-06 | 196 | 173 | 8 | 90edf61116ffcb4f8b6be3d0a05732d59b0a87d5 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-outer_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-06 | 196 | 173 | 8 | c936014125b2ed5f796221b74acb77b8f8359875 | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.07e-06 | 197 | 173 | 8 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.11e-06 | 198 | 173 | 8 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | COVID-19-lung|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.15e-06 | 199 | 173 | 8 | 155b03b859157013e9142e9248551369127d9204 | |
| ToppCell | facs-Spleen-nan-24m-Myeloid|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.65e-06 | 156 | 173 | 7 | 034d4359359a44c205c6931f38a375271ac2752b | |
| ToppCell | facs-Spleen-nan-24m-Myeloid-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.65e-06 | 156 | 173 | 7 | 2a4dac4100c0339aad4905b8eaca6e8fe806718b | |
| ToppCell | facs-Spleen-nan-24m-Myeloid-granulocyte|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.65e-06 | 156 | 173 | 7 | 21267718d3a3dc19988663b6846aed8bb3eae836 | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|RV / Chamber and Cluster_Paper | 3.26e-06 | 161 | 173 | 7 | 47b3b7662cbb671ccc086dc0a0cabd65f63eb5a1 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.26e-06 | 161 | 173 | 7 | 2849fbc9611af208241b33da3cd18290aafe426b | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-Klrb1a/b/c(-)_NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.84e-06 | 165 | 173 | 7 | 651d40eadb1b34de618af94c167f43635729d43f | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage_2|368C / Donor, Lineage, Cell class and subclass (all cells) | 4.85e-06 | 171 | 173 | 7 | 26b34dc069cc15b75a0c13cb8c5d81e074788160 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 7.90e-06 | 121 | 173 | 6 | 19333a660800b583fa27b495c1f7828e6636a257 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.42e-06 | 186 | 173 | 7 | 4780af76237d7af2abbe2d8d5530cdf53e3ed0b7 | |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 8.72e-06 | 187 | 173 | 7 | 464a0c3b92b778911b5f9cd73642e09e3472063a | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 9.02e-06 | 188 | 173 | 7 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.34e-06 | 189 | 173 | 7 | b6b4da51bc7f2c13a2f940540fdc61027d084835 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.67e-06 | 190 | 173 | 7 | 1121eb607a984c59fbffe7220837fc178745aa55 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.67e-06 | 190 | 173 | 7 | 048b581e3f7ea9fc2f87c0532974bba85c7292c2 | |
| ToppCell | PCW_13-14|World / Celltypes from embryonic and fetal-stage human lung | 9.67e-06 | 190 | 173 | 7 | 62a3ec1ae0829602b0569cc051210551644f1d46 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 1.00e-05 | 191 | 173 | 7 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.00e-05 | 191 | 173 | 7 | 3387b95a3f2445c672d407922fdce3a91eabaef8 | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.00e-05 | 191 | 173 | 7 | f76f3f5c7902a3659d8cbe470f96ce57c8a6744d | |
| ToppCell | Control-Stromal-SMC|Stromal / Disease state, Lineage and Cell class | 1.00e-05 | 191 | 173 | 7 | 2da83c493e60ad0278848957645277d76737a188 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.00e-05 | 191 | 173 | 7 | a251b134f67a0a1ef3a42f50042f128a17f20b22 | |
| ToppCell | COVID-19-Endothelial_cells-Inflamed_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 1.07e-05 | 193 | 173 | 7 | 979ebefa527f86bebeea5d94e626ee6c1cc7d53b | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 1.07e-05 | 193 | 173 | 7 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | facs-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-05 | 195 | 173 | 7 | bd8e24dd598990204998d1dd853ba7a53dc0107e | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.14e-05 | 195 | 173 | 7 | 0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937 | |
| ToppCell | T_cells-CTLs|World / Immune cells in Kidney/Urine in Lupus Nephritis | 1.22e-05 | 197 | 173 | 7 | 2de34e20915a247bee75aa40495e23c20bb23e18 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.26e-05 | 198 | 173 | 7 | 17dc055e2a289496d9c5cdbf3297bdf906dc6d22 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.26e-05 | 198 | 173 | 7 | 21cf4d81386761d09d0f6829c01c198e5524176d | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.31e-05 | 199 | 173 | 7 | 333056c2abe9724efeab542c0365fcfe4eff8f18 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.31e-05 | 199 | 173 | 7 | 19a97e27a4758e794ce7246d295e112b47931a48 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.31e-05 | 199 | 173 | 7 | e60ecbb8fa7bcd3e2ce7d78f6efb2cfd1fd77698 | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.35e-05 | 200 | 173 | 7 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.35e-05 | 200 | 173 | 7 | a66449b22b39dd6987fc2c3ed160d24564234ced | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.35e-05 | 200 | 173 | 7 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 2.39e-05 | 147 | 173 | 6 | 94998bc40f5c08295cfe3bdcbe43f13b1e564b3d | |
| ToppCell | 368C-Myeloid-Monocyte-CD16+_Monocyte|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.34e-05 | 156 | 173 | 6 | 25b0936960be4955b6a6d6b8a867fdd4be548f05 | |
| ToppCell | control-B_cell|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.46e-05 | 157 | 173 | 6 | 1269b55f2ef6a493f6116b131cc5cc7b8897d63e | |
| ToppCell | COVID-19_Severe-NK_CD56bright|World / disease group, cell group and cell class | 3.46e-05 | 157 | 173 | 6 | 9dcbabb377da7e93ec9f9abf09576a92877a7e02 | |
| ToppCell | facs-Brain_Myeloid-Striatum_-18m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.46e-05 | 157 | 173 | 6 | 9d4308312301cb922f156a7b6aededc9e1c62807 | |
| ToppCell | COVID-19_Severe-NK_CD56bright|COVID-19_Severe / disease group, cell group and cell class | 3.72e-05 | 159 | 173 | 6 | 9e2067f0d76769717f7048dab505fadd36bbb83e | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 3.85e-05 | 160 | 173 | 6 | 29c9b4770d0e73d59cffc7937b179484c76b6dcc | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.99e-05 | 161 | 173 | 6 | 5fba13f0aa5002f7eefe219e2c6a07e163f1a50d | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 4.13e-05 | 162 | 173 | 6 | b4535bcb3f469bc139e73f1122f4070013e5a1de | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.89e-05 | 167 | 173 | 6 | 774f3264318b002d0df5d06d41d645366038d0bf | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 5.22e-05 | 169 | 173 | 6 | c6e5b179461996ced6c7621dc01cec00d401f4e8 | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage_2|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 5.22e-05 | 169 | 173 | 6 | ea600c63cf9572bc4b3cad6392f67bd0d92c7fc9 | |
| ToppCell | droplet-Spleen-nan-3m-Myeloid-granulocyte|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.40e-05 | 170 | 173 | 6 | dbd6c9c7be824a1ff1b31af791064127cafbd194 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 5.58e-05 | 171 | 173 | 6 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | mild-Myeloid-Eosinophils|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 5.58e-05 | 171 | 173 | 6 | 5c8198182495bda7a826e9d80aa467f4eb1094ec | |
| ToppCell | Club-club-1|World / Class top | 5.75e-05 | 54 | 173 | 4 | 48f80b20b1c4995a0f7084d31666781dce4009a9 | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell|Adult / Lineage, Cell type, age group and donor | 5.76e-05 | 172 | 173 | 6 | c62cad0f4212d1e9ea1ec3143ad3c4e06aff0ebf | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Myeloid-macrophage_dendritic_cell_progenitor|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.76e-05 | 172 | 173 | 6 | 30916a902c151907745756d14327e24adc34afef | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-plasmacytoid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.95e-05 | 173 | 173 | 6 | 1b9b4e165121b08ef15a93fca6bea875cae69f19 | |
| ToppCell | droplet-Lung-21m-Epithelial-airway_epithelial|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.95e-05 | 173 | 173 | 6 | a809be2630d2b91b53b82b5e2bb99e05524597c1 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.95e-05 | 173 | 173 | 6 | cb6389536195443633adb06e5f1b7483530773d1 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-Plasmacytoid_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.95e-05 | 173 | 173 | 6 | c25f24d7b672c9686d31ebc8d263042282f520fd | |
| ToppCell | mild_COVID-19_(asymptomatic)-gd_T|World / disease group, cell group and cell class (v2) | 5.95e-05 | 173 | 173 | 6 | b6615ff02f5017d7150b1e33b53f8c7a26081a0d | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_E|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 6.14e-05 | 174 | 173 | 6 | a1f745962a104c6f4b86b7e482da8755384c773a | |
| ToppCell | Control-Epithelial_cells-AT1|Control / group, cell type (main and fine annotations) | 6.14e-05 | 174 | 173 | 6 | 548d7f2b958a2bfd2c95eb049ceaab55a559c77d | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.54e-05 | 176 | 173 | 6 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.96e-05 | 178 | 173 | 6 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.18e-05 | 179 | 173 | 6 | 8ce5000088b727783a0619baa16a2cd036d21f54 | |
| ToppCell | Control-Fibroblasts-Airway_smooth_muscle|Control / group, cell type (main and fine annotations) | 7.41e-05 | 180 | 173 | 6 | d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1 | |
| ToppCell | wk_20-22-Hematologic-Myeloid-pDC|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 7.64e-05 | 181 | 173 | 6 | 60607c5ff6d5b1cb416adc034491dca31c41e988 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_NK-NK_bright-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 7.64e-05 | 181 | 173 | 6 | 9c4f9abb9335da2b07644bca8faff1baa1bb9f5b | |
| ToppCell | Club-club-8|World / Class top | 7.87e-05 | 182 | 173 | 6 | 8111d917e588008d947021460ddf8f1e7ae1337a | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|RA / Chamber and Cluster_Paper | 8.11e-05 | 183 | 173 | 6 | 818fd886e0188091310825f9145fa53328f2c979 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.11e-05 | 183 | 173 | 6 | 8a799807fbf24456a9811e0c64068187940a2f71 | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 8.11e-05 | 183 | 173 | 6 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | B_cells-ISG-high_B_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 8.11e-05 | 183 | 173 | 6 | dc2b00e920efa1dcc2a6265cd1024e3249c9974f | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 8.11e-05 | 183 | 173 | 6 | cae2ee08f985a6f005b4b8e959e465350315156a | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D122|Adult / Lineage, Cell type, age group and donor | 8.36e-05 | 184 | 173 | 6 | 2b7e6f91e11c228f0521e099886867d9e998e78d | |
| Drug | plakin | 1.91e-07 | 82 | 171 | 8 | CID000018752 | |
| Drug | Nefopam hydrochloride [23327-57-3]; Up 200; 13.8uM; HL60; HT_HG-U133A | MRAS MAP1B KDM4C MYOF PDE12 MBTPS2 SLC15A2 TECPR2 ZFHX2 SNAPC4 | 2.41e-06 | 196 | 171 | 10 | 2355_UP |
| Drug | AC1L88YH | 6.77e-06 | 17 | 171 | 4 | CID000374551 | |
| Drug | mag-fura-2 | 8.09e-06 | 37 | 171 | 5 | CID000123839 | |
| Drug | mono-(2-ethylhexyl)phthalate | LRRC66 RSPH4A MAP1B KALRN PEX1 ITGA3 GABBR2 RGS7 ABCC6 NDUFS5 SPTBN4 SPTBN5 DST KNDC1 ULK1 DMD PDZRN4 | 1.01e-05 | 658 | 171 | 17 | ctd:C016599 |
| Drug | Dihydroergotoxine mesylate [8067-24-1]; Down 200; 6.4uM; MCF7; HT_HG-U133A | 1.67e-05 | 194 | 171 | 9 | 2793_DN | |
| Drug | Asiaticoside [16830-15-2]; Down 200; 4.2uM; MCF7; HT_HG-U133A | 1.74e-05 | 195 | 171 | 9 | 7004_DN | |
| Drug | Metrizamide [31112-62-6]; Up 200; 5uM; HL60; HT_HG-U133A | 1.74e-05 | 195 | 171 | 9 | 1318_UP | |
| Drug | Thyroxine (L) [51-48-9]; Up 200; 5.2uM; PC3; HT_HG-U133A | 1.89e-05 | 197 | 171 | 9 | 4069_UP | |
| Drug | Clindamycin hydrochloride [21462-39-5]; Down 200; 8.6uM; PC3; HT_HG-U133A | 1.89e-05 | 197 | 171 | 9 | 5815_DN | |
| Drug | compound 48/80 | 1.92e-05 | 151 | 171 | 8 | CID000104735 | |
| Drug | Cortisone [53-06-5]; Down 200; 11uM; MCF7; HT_HG-U133A | 1.96e-05 | 198 | 171 | 9 | 7416_DN | |
| Drug | Cinnarizine | 3.38e-05 | 9 | 171 | 3 | DB00568 | |
| Drug | Nimodipine | 3.38e-05 | 9 | 171 | 3 | DB00393 | |
| Drug | mant-GTP | 3.63e-05 | 50 | 171 | 5 | CID000128647 | |
| Drug | ATP-EDC | 4.81e-05 | 10 | 171 | 3 | CID000195647 | |
| Drug | 1sqc | 4.81e-05 | 10 | 171 | 3 | CID000444279 | |
| Drug | magnesium fluoride | 4.83e-05 | 53 | 171 | 5 | CID000024546 | |
| Drug | Peroxybenzoylnitrate | 5.61e-05 | 2 | 171 | 2 | CID000036112 | |
| Drug | peroxypropionyl nitrate | 5.61e-05 | 2 | 171 | 2 | CID000022041 | |
| Drug | Mibefradil | 6.57e-05 | 11 | 171 | 3 | DB01388 | |
| Drug | 2,5-dimethylquinone | 6.57e-05 | 11 | 171 | 3 | CID000008718 | |
| Drug | ethylketocyclazocine | 7.49e-05 | 58 | 171 | 5 | CID000135018 | |
| Drug | 1vyq | 8.71e-05 | 12 | 171 | 3 | CID004369390 | |
| Drug | Proguanil hydrochloride [637-32-1]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 1.05e-04 | 192 | 171 | 8 | 3505_DN | |
| Drug | Ricinine [524-40-3]; Down 200; 24.4uM; HL60; HT_HG-U133A | 1.09e-04 | 193 | 171 | 8 | 2505_DN | |
| Drug | rapamycin, Streptomyces hygroscepicus; Up 200; 0.1uM; PC3; HT_HG-U133A | 1.09e-04 | 193 | 171 | 8 | 5932_UP | |
| Drug | dihydropyridine | 1.09e-04 | 193 | 171 | 8 | CID000104822 | |
| Drug | nimodipine | 1.15e-04 | 145 | 171 | 7 | CID000004497 | |
| Drug | Dantrolene-13C3 | 1.15e-04 | 145 | 171 | 7 | CID000002951 | |
| Drug | Dinoprost trometamol [38362-01-5]; Down 200; 8.4uM; HL60; HT_HG-U133A | 1.17e-04 | 195 | 171 | 8 | 2446_DN | |
| Drug | Tinidazole [19387-91-8]; Down 200; 16.2uM; HL60; HT_HG-U133A | 1.17e-04 | 195 | 171 | 8 | 2568_DN | |
| Drug | dimyristoylphosphatidylcholine | 1.20e-04 | 64 | 171 | 5 | CID000026197 | |
| Drug | oligomycin; Down 200; 1uM; MCF7; HG-U133A | 1.21e-04 | 196 | 171 | 8 | 442_DN | |
| Drug | Quinic acid [86-68-0]; Down 200; 19.6uM; HL60; HT_HG-U133A | 1.21e-04 | 196 | 171 | 8 | 2978_DN | |
| Drug | Dipivefrin hydrochloride [64019-93-8]; Down 200; 10.4uM; PC3; HT_HG-U133A | 1.21e-04 | 196 | 171 | 8 | 7124_DN | |
| Drug | Cyproheptadine hydrochloride [969-33-5]; Up 200; 12.4uM; PC3; HT_HG-U133A | 1.21e-04 | 196 | 171 | 8 | 6740_UP | |
| Drug | Riluzole hydrochloride; Up 200; 14.8uM; HL60; HT_HG-U133A | 1.26e-04 | 197 | 171 | 8 | 2334_UP | |
| Drug | nordihydroguaiaretic acid; Up 200; 1uM; ssMCF7; HG-U133A | 1.26e-04 | 197 | 171 | 8 | 415_UP | |
| Drug | Fenofibrate [49562-28-9]; Up 200; 11uM; HL60; HT_HG-U133A | 1.26e-04 | 197 | 171 | 8 | 2401_UP | |
| Drug | thioridazine hydrochloride; Up 200; 1uM; MCF7; HG-U133A | 1.26e-04 | 197 | 171 | 8 | 422_UP | |
| Drug | Ethacrynic acid [58-54-8]; Down 200; 13.2uM; PC3; HT_HG-U133A | 1.30e-04 | 198 | 171 | 8 | 5742_DN | |
| Drug | Levamisole hydrochloride [16595-80-5]; Down 200; 16.6uM; MCF7; HT_HG-U133A | 1.30e-04 | 198 | 171 | 8 | 7450_DN | |
| Drug | Trimethoprim [738-70-5]; Up 200; 13.8uM; HL60; HT_HG-U133A | 1.30e-04 | 198 | 171 | 8 | 2345_UP | |
| Drug | wortmannin; Down 200; 0.01uM; ssMCF7; HG-U133A | 1.35e-04 | 199 | 171 | 8 | 404_DN | |
| Drug | PF-00562151-00 [351320-12-2]; Up 200; 10uM; PC3; HT_HG-U133A | 1.35e-04 | 199 | 171 | 8 | 5959_UP | |
| Drug | Mephenesin [59-47-2]; Up 200; 22uM; PC3; HT_HG-U133A | 1.35e-04 | 199 | 171 | 8 | 7374_UP | |
| Drug | nordihydroguaiaretic acid; Up 200; 1uM; HL60; HT_HG-U133A | 1.35e-04 | 199 | 171 | 8 | 6182_UP | |
| Drug | Piracetam [7491-74-9]; Down 200; 28.2uM; HL60; HG-U133A | 1.40e-04 | 200 | 171 | 8 | 1710_DN | |
| Drug | Bay K 8644 | 1.42e-04 | 150 | 171 | 7 | CID000002303 | |
| Drug | p-hydroxyhippuric acid | 1.43e-04 | 14 | 171 | 3 | CID000151012 | |
| Disease | Brody myopathy (implicated_via_orthology) | 1.78e-07 | 3 | 167 | 3 | DOID:0050692 (implicated_via_orthology) | |
| Disease | Timothy syndrome (implicated_via_orthology) | 7.09e-07 | 4 | 167 | 3 | DOID:0060173 (implicated_via_orthology) | |
| Disease | Short Stature, CTCAE | 2.08e-05 | 10 | 167 | 3 | C2919142 | |
| Disease | Short stature | 2.08e-05 | 10 | 167 | 3 | C0349588 | |
| Disease | Anemia, Hemolytic, Congenital | 3.18e-05 | 2 | 167 | 2 | C0002881 | |
| Disease | Duchenne muscular dystrophy (implicated_via_orthology) | 5.06e-05 | 36 | 167 | 4 | DOID:11723 (implicated_via_orthology) | |
| Disease | Rh Deficiency Syndrome | 9.52e-05 | 3 | 167 | 2 | C0272052 | |
| Disease | Rh-Null, Regulator Type | 9.52e-05 | 3 | 167 | 2 | C1849387 | |
| Disease | Autosomal dominant Emery-Dreifuss muscular dystrophy | 1.90e-04 | 4 | 167 | 2 | cv:CN293514 | |
| Disease | arthrogryposis multiplex congenita (is_implicated_in) | 1.90e-04 | 4 | 167 | 2 | DOID:0080954 (is_implicated_in) | |
| Disease | phosphatidylcholine measurement | 2.26e-04 | 284 | 167 | 8 | EFO_0010226 | |
| Disease | Autosomal Recessive Emery-Dreifuss Muscular Dystrophy | 3.15e-04 | 5 | 167 | 2 | C1450051 | |
| Disease | Autosomal Dominant Emery-Dreifuss Muscular Dystrophy (disorder) | 3.15e-04 | 5 | 167 | 2 | C0410190 | |
| Disease | Perineurioma | 3.15e-04 | 5 | 167 | 2 | C0751691 | |
| Disease | Nerve Sheath Tumors | 3.15e-04 | 5 | 167 | 2 | C0206727 | |
| Disease | Peripheral Nerve Sheath Neoplasm | 3.15e-04 | 5 | 167 | 2 | C0751689 | |
| Disease | diacylglycerol 44:6 measurement | 3.15e-04 | 5 | 167 | 2 | EFO_0020070 | |
| Disease | Schwannomatosis, Plexiform | 3.15e-04 | 5 | 167 | 2 | C0751374 | |
| Disease | hemolytic-uremic syndrome (is_marker_for) | 3.15e-04 | 5 | 167 | 2 | DOID:12554 (is_marker_for) | |
| Disease | Dwarfism | 3.74e-04 | 25 | 167 | 3 | C0013336 | |
| Disease | Emery-Dreifuss muscular dystrophy | 4.71e-04 | 6 | 167 | 2 | cv:C0410189 | |
| Disease | Muscular Dystrophy, Emery-Dreifuss | 4.71e-04 | 6 | 167 | 2 | C0410189 | |
| Disease | Neurilemmoma | 4.71e-04 | 6 | 167 | 2 | C0027809 | |
| Disease | neuropathy (implicated_via_orthology) | 4.71e-04 | 6 | 167 | 2 | DOID:870 (implicated_via_orthology) | |
| Disease | Coronary Arteriosclerosis | 5.12e-04 | 65 | 167 | 4 | C0010054 | |
| Disease | Coronary Artery Disease | 5.12e-04 | 65 | 167 | 4 | C1956346 | |
| Disease | Polydactyly | 5.50e-04 | 117 | 167 | 5 | C0152427 | |
| Disease | pulmonary hypertension (is_implicated_in) | 6.46e-04 | 30 | 167 | 3 | DOID:6432 (is_implicated_in) | |
| Disease | X-Linked Emery-Dreifuss Muscular Dystrophy | 6.56e-04 | 7 | 167 | 2 | C0751337 | |
| Disease | Hepatitis B, Chronic | 8.72e-04 | 8 | 167 | 2 | C0524909 | |
| Disease | Intellectual Disability | 1.06e-03 | 447 | 167 | 9 | C3714756 | |
| Disease | Adenoma, Microcystic | 1.11e-03 | 36 | 167 | 3 | C0205648 | |
| Disease | Adenoma, Monomorphic | 1.11e-03 | 36 | 167 | 3 | C0205649 | |
| Disease | Adenoma, Basal Cell | 1.11e-03 | 36 | 167 | 3 | C0205646 | |
| Disease | Follicular adenoma | 1.11e-03 | 36 | 167 | 3 | C0205647 | |
| Disease | Papillary adenoma | 1.11e-03 | 36 | 167 | 3 | C0205650 | |
| Disease | Adenoma, Trabecular | 1.11e-03 | 36 | 167 | 3 | C0205651 | |
| Disease | Adenoma | 1.11e-03 | 36 | 167 | 3 | C0001430 | |
| Disease | retinal detachment (biomarker_via_orthology) | 1.12e-03 | 9 | 167 | 2 | DOID:5327 (biomarker_via_orthology) | |
| Disease | Malignant neoplasm of breast | KALRN SYNE1 STAT1 RHD NF1 ARAP3 HP WDCP SYNE2 NLRC5 MACF1 FGFR1 HERC2 DMD ATP2A3 | 1.21e-03 | 1074 | 167 | 15 | C0006142 |
| Disease | heart disease (implicated_via_orthology) | 1.30e-03 | 38 | 167 | 3 | DOID:114 (implicated_via_orthology) | |
| Disease | Anemia, Sickle Cell | 1.39e-03 | 10 | 167 | 2 | C0002895 | |
| Disease | influenza A (H1N1) | 1.53e-03 | 87 | 167 | 4 | EFO_1001488 | |
| Disease | revision of total hip arthroplasty, aseptic loosening | 1.74e-03 | 42 | 167 | 3 | EFO_0010725, EFO_0020973 | |
| Disease | Emery-Dreifuss muscular dystrophy (implicated_via_orthology) | 2.02e-03 | 12 | 167 | 2 | DOID:11726 (implicated_via_orthology) | |
| Disease | alcohol use disorder measurement, alcohol consumption measurement | 2.28e-03 | 97 | 167 | 4 | EFO_0007878, EFO_0009458 | |
| Disease | sphingomyelin 18:1 measurement | 2.38e-03 | 13 | 167 | 2 | EFO_0010394 | |
| Disease | coronary artery disease (is_implicated_in) | 2.55e-03 | 100 | 167 | 4 | DOID:3393 (is_implicated_in) | |
| Disease | Major Depressive Disorder | 2.68e-03 | 243 | 167 | 6 | C1269683 | |
| Disease | Malformations of Cortical Development | 2.77e-03 | 14 | 167 | 2 | C1955869 | |
| Disease | Cortical Dysplasia | 2.77e-03 | 14 | 167 | 2 | C0431380 | |
| Disease | vascular dementia (biomarker_via_orthology) | 2.77e-03 | 14 | 167 | 2 | DOID:8725 (biomarker_via_orthology) | |
| Disease | complement factor H-related protein 3 measurement | 2.81e-03 | 169 | 167 | 5 | EFO_0600056 | |
| Disease | HIV Infections | 2.83e-03 | 103 | 167 | 4 | C0019693 | |
| Disease | HIV Coinfection | 2.83e-03 | 103 | 167 | 4 | C4505456 | |
| Disease | calcium measurement | AAK1 ABCC6 SPPL2A IGFALS SLC15A2 SYNE2 MACF1 FGFR1 FBXL20 ATP2A2 | 3.18e-03 | 628 | 167 | 10 | EFO_0004838 |
| Disease | allergic disease | 3.60e-03 | 258 | 167 | 6 | MONDO_0005271 | |
| Disease | body mass index, type 2 diabetes mellitus | 3.63e-03 | 16 | 167 | 2 | EFO_0004340, MONDO_0005148 | |
| Disease | Unipolar Depression | 3.67e-03 | 259 | 167 | 6 | C0041696 | |
| Disease | Moyamoya Disease | 4.10e-03 | 17 | 167 | 2 | C0026654 | |
| Disease | pyruvate measurement | 4.33e-03 | 268 | 167 | 6 | EFO_0010117 | |
| Disease | glucose homeostasis measurement, acute insulin response measurement | 4.59e-03 | 18 | 167 | 2 | EFO_0006831, EFO_0006896 | |
| Disease | Idiopathic hypogonadotropic hypogonadism | 4.59e-03 | 18 | 167 | 2 | C0342384 | |
| Disease | schizophrenia, inflammatory bowel disease | 4.59e-03 | 18 | 167 | 2 | EFO_0003767, MONDO_0005090 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LLEINWTGLTNLLDV | 326 | A0FGR8 | |
| VILQNNEFGTIIDWA | 141 | O42043 | |
| AVILQNNEFGTIIDW | 251 | O71037 | |
| AVILQNNEFGTIIDW | 251 | Q902F8 | |
| WSNEIVQLFIVLGND | 551 | Q8WWN8 | |
| VLNEDQALSALINWV | 191 | Q13939 | |
| INNVSSGDVWEVLIL | 111 | Q2M2I8 | |
| IIWNVGTGEALINLD | 156 | Q9ULV4 | |
| WGLAELLELDLTSNQ | 431 | P35858 | |
| FLSLNWAQGDVSLEI | 471 | Q96M93 | |
| VDEAWALLQGLQSRV | 166 | Q6Q788 | |
| IWSNELIELFIVIGN | 746 | Q8WZ64 | |
| NAELVLLTLGQAWQG | 66 | O76075 | |
| GLEEVQWCLEQLLTS | 521 | Q8N531 | |
| VLSWLLSAEDTLQAQ | 351 | P11532 | |
| NFRVVLVGLEIWNSQ | 241 | P78325 | |
| VDRSLLLQGWQDQAF | 216 | Q13319 | |
| IAELAQASNSLIAWG | 291 | Q96HY6 | |
| LILIANAIVGVWQER | 96 | O14983 | |
| LILVANAIVGVWQER | 96 | Q93084 | |
| GTGWLLELLSEVQLQ | 6 | Q07912 | |
| NLIITGSLDALIQVW | 1141 | Q149M9 | |
| GSLDALIQVWSLSEQ | 1146 | Q149M9 | |
| LIQVWSLSEQGTLLD | 1151 | Q149M9 | |
| IDNQWAILDVLDTAG | 56 | O14807 | |
| RTNLDLVLDWLQGAG | 806 | Q5U651 | |
| AQLWALQGEVQLTAR | 176 | Q6ZMN7 | |
| AETQLQAALLKNAWL | 601 | A6NNM3 | |
| AETQLQAALLKNAWL | 601 | A6NJZ7 | |
| DEAGNLFVWRLALVN | 196 | Q6P2E9 | |
| NNETLLGEDLVAWVT | 661 | O75106 | |
| LLTVFQILTGEDWNV | 701 | O60840 | |
| LVLNDGVLWDVRSAQ | 1236 | Q9Y4B6 | |
| DTAWISALALAVQQA | 76 | Q8NCK7 | |
| IGNIELGIRSWDTNL | 56 | P46821 | |
| NQLWNGIISITLLEG | 351 | Q6DN12 | |
| AVIALLLWGQLFAVD | 6 | P00738 | |
| AQTVNLLAEWLIQTG | 91 | Q8IXH7 | |
| RSALANQIDWTEIGL | 366 | O60524 | |
| LGQLGNLWQLDTEDL | 591 | Q38SD2 | |
| VVVWNLALGEEAVAN | 721 | Q38SD2 | |
| LALGEEAVANLQFWL | 726 | Q38SD2 | |
| EAVANLQFWLLNIEA | 731 | Q38SD2 | |
| LLLLQLWDSGAQETD | 311 | O95714 | |
| SGQFTDALQALIDWL | 6816 | Q03001 | |
| ILGIVWVASALIDND | 161 | Q8WVP7 | |
| IALADLNNDGWQDLL | 311 | P26006 | |
| VLFGNGTLLVLIWND | 36 | Q9Y5P0 | |
| VLNVDAWQDGAVLQI | 136 | Q6L8Q7 | |
| DLELSWNLNGLQADL | 106 | P06734 | |
| GIFWLNASETLVEIN | 281 | Q8TET4 | |
| LNITWGDQDLLNIVF | 311 | Q4G148 | |
| VQGELILQDAFQVWD | 1471 | O60229 | |
| AAWSLGNLTDTLIVN | 876 | Q6AI08 | |
| EENQESLRSLGAWNL | 886 | P48681 | |
| GVDEWNIARLNTVLD | 146 | Q9H3R0 | |
| FINWLTLAEQSLNIA | 2581 | O94854 | |
| LAWVDLGNNVDVASL | 241 | Q2VPJ9 | |
| RLWNIQTDTLVAIFG | 216 | O75530 | |
| DINRLDSTGVNVLLW | 111 | Q5TYM5 | |
| GFQNLLEWQALLFVI | 16 | Q8NGX0 | |
| IILVNTSDWQGQFLS | 491 | Q86VP3 | |
| ATLQWLLAENAAVDV | 731 | Q0VG06 | |
| AVILQNNEFGTIIDW | 1011 | P63135 | |
| LDLSFNGILQIGWSD | 176 | Q68CR7 | |
| NQITALGAWLLAEGL | 1806 | Q86WI3 | |
| LQEFINWLTLAEQSL | 6451 | Q9UPN3 | |
| LELNVIVTVWNAGED | 796 | Q13349 | |
| EQLAGWILQSRGLEA | 671 | Q96JP2 | |
| TAQQGLDQIWLLLAI | 21 | Q9H237 | |
| DADQLLGIGQNWSTI | 391 | P87889 | |
| DADQLLGIGQNWSTI | 391 | Q9YNA8 | |
| DADQLLGIGQNWSTI | 391 | P62683 | |
| DADQLLGIGQNWSTI | 391 | P63145 | |
| DADQLLGIGQNWSTI | 391 | Q7LDI9 | |
| DADQLLGIGQNWSTI | 391 | P63130 | |
| DADQLLGIGQNWSTI | 391 | P62685 | |
| DADQLLGIGQNWSTI | 391 | P63126 | |
| DADQLLGIGQNWSTI | 391 | P62684 | |
| LILVANAIVGVWQER | 96 | P16615 | |
| LAAVLWQLNGTKITD | 246 | Q01638 | |
| WEEEQSLASQLGVAL | 261 | P0C671 | |
| LLTVFQILTGEDWNS | 696 | Q13936 | |
| GVLDLNWAAEVLDVQ | 151 | Q14209 | |
| NILLWNGLLTDDTLQ | 656 | P16383 | |
| VILQNNEFGTIIDWA | 141 | P61566 | |
| AVILQNNEFGTIIDW | 251 | P61570 | |
| AVILQNNEFGTIIDW | 251 | Q69384 | |
| VILQNNEFGTIIDWA | 141 | P61567 | |
| VQSINWLRDGVQLAE | 61 | P11362 | |
| SQTCDWGNLLQDIIL | 31 | Q9UKT7 | |
| NDAVLLWIAIIATLG | 56 | Q9NPU4 | |
| ILIWEDGSLEINNIT | 461 | Q12860 | |
| ADLNLVQALRQFLWS | 141 | O43739 | |
| QAVEVWQGLALLSEA | 86 | P01588 | |
| VLLSAGGDNVIIIWN | 146 | Q6QEF8 | |
| VILQNNEFGTIIDWA | 251 | P61565 | |
| VILQNNEFGTIIDWA | 141 | Q9HDB8 | |
| LDGQWILNSFLDATL | 466 | O43462 | |
| ILDWSFQNLVAIALG | 236 | Q86Y33 | |
| IIAESLQGWNLVQLS | 141 | O75899 | |
| VSELTLGQIWDVDLQ | 1426 | Q14204 | |
| EQWVSLQDLLSQLGR | 441 | Q76NI1 | |
| AVILQNNEFGTLIDW | 251 | Q902F9 | |
| GWLINIENSLSLAAV | 231 | Q8NFI3 | |
| NVIAALNSRTGEILW | 61 | Q8N766 | |
| EALVLLQLWANLDVL | 221 | A4GXA9 | |
| AITLLEQNNWDLVAA | 26 | Q9UNN5 | |
| LLATQAVALAWSPQE | 11 | P09228 | |
| VRQLAASLWEDVGLQ | 301 | Q86Y56 | |
| WLDLSFNNIETIEGL | 91 | Q9H069 | |
| QAAWLLTIAVGNIIV | 646 | Q16348 | |
| QGIVILSRSWAVDLN | 436 | Q68D06 | |
| ACVLQVVWNGLEELN | 381 | O43933 | |
| LTVFQILTGEDWNAV | 696 | Q01668 | |
| QANIWLFEDTVLITG | 171 | Q6P995 | |
| AQNNLGILWSEREEI | 141 | Q96EK5 | |
| RGQLASLWALLQQEE | 181 | Q0P6D2 | |
| WLVSQLDLGQLEGVA | 11 | Q14653 | |
| LIWNGNAVSGLDALN | 46 | Q9NPJ8 | |
| VQVWALGSDQLLQEL | 771 | Q92918 | |
| TLWIQFQEGLASSIQ | 356 | Q8N8U3 | |
| GIQVIDLVESLSNWV | 531 | Q5TD94 | |
| LTLQDLDNIWAAQAG | 426 | Q93008 | |
| VFSGSDIVQWLIKNL | 56 | P49802 | |
| LALIAEQGLENSWRQ | 276 | P21549 | |
| LDQLQNWFTIVAESL | 256 | P42224 | |
| IDILKLVAAQVGSQW | 416 | O75509 | |
| GIWIASQLLRQIEAL | 161 | O14545 | |
| GVIDRWELLQAQALS | 8416 | Q8NF91 | |
| AQLSELRLDGNVVIW | 281 | Q8N3T6 | |
| RQLSLLWEAAQGAVD | 6636 | Q8WXH0 | |
| ESARWLIINNQLDEG | 281 | Q8N4F4 | |
| TFIGQEILDSWISLN | 291 | Q86VH5 | |
| VADRWLAANVELLGN | 1166 | O95255 | |
| AETQLQAALLKNAWL | 601 | Q9UFD9 | |
| NVLALDGSNWQRIDL | 56 | Q96IG2 | |
| GLNIDRWLTIQSGEQ | 11 | O43920 | |
| VVDRALGQSWLEVQL | 141 | P58107 | |
| ISAAILEILNAWENG | 581 | O75448 | |
| LEILNAWENGVLAFE | 586 | O75448 | |
| WGANGLDAIITQLLN | 181 | Q9BV68 | |
| WILRLQNLIENDSGV | 96 | P03979 | |
| ALQVLSIGSQWARAE | 1016 | Q6ZUB1 | |
| LIVKGFNVVSAWALQ | 141 | Q8NFT2 | |
| SNILEAWSEGVALLQ | 126 | Q9BUA3 | |
| TNLDLSINQIARGLW | 906 | Q8WX94 | |
| LVTANNLFQLFIGWE | 131 | P03915 | |
| VGQLLAVNAEEDAWL | 516 | Q8NHU6 | |
| SEINGIILVGLWITQ | 131 | Q8NHU3 | |
| AVETGWLQLLDQAGN | 36 | P29371 | |
| AQAFLLEQQLWGVEL | 171 | Q5SWA1 | |
| FINAALSWLGELVDI | 436 | O43868 | |
| SFLQESQQLLLWAES | 1106 | Q9NRC6 | |
| AQQFLTELLEAGSWL | 3001 | Q9NRC6 | |
| AANNAEISVQLGLEW | 361 | O94993 | |
| DADQLLGIGQNWSTI | 391 | P63128 | |
| GNELTVADVVLWSVL | 271 | Q13155 | |
| VWTETLIELFLQLGN | 596 | Q96P48 | |
| INWNLTDLVNTGLSA | 116 | Q8IZR5 | |
| NSLVWILENDITGVL | 531 | Q9HAU4 | |
| VELVFSGNRLDILWN | 611 | Q9NR97 | |
| EGLFWQTLRNVVLTE | 1011 | Q9NR97 | |
| GSSELLWNEIIILNV | 61 | O00308 | |
| GLDRQIFLWDVNTLT | 136 | Q8TAF3 | |
| WTSGLLEINETLVIQ | 6 | Q86VN1 | |
| LLGLASRVVVVWFQN | 1631 | Q9C0A1 | |
| LGVQWAILLDGFLSQ | 86 | Q02161 | |
| LGVQWAILLDGFLSQ | 86 | P18577 | |
| VWRGEAQDLLSQIAQ | 111 | Q5EBL4 | |
| GWNECEQTVALLSLL | 16 | Q5PRF9 | |
| LASVTLGIWQTVNEL | 426 | Q9P2C4 | |
| LRQSVGNEAEIWLGL | 121 | P05452 | |
| QVDEANLLTWQGLIV | 26 | A0A1B0GUS4 | |
| EQLRWLTVFQQAGDI | 1301 | O75038 | |
| LFNVQDQHDLLTLGW | 331 | Q96FJ0 | |
| WGFLLQLTAAQEAIL | 16 | Q8TCT8 | |
| LITWNIDGLDLNNLS | 116 | O95551 | |
| LASAGQDNVVRIWAL | 526 | Q5JSH3 | |
| FWVAVAVLQLDEVNL | 2316 | P21359 | |
| QWRLSGLEAALQALE | 1021 | Q9H254 | |
| LEQLQSAWAGLREAA | 1596 | Q9H254 | |
| INLEFLVNRNLAASW | 1321 | Q709C8 | |
| VCITLGDQQTLWALD | 986 | O15040 | |
| ALTLQDLDNIWAAQA | 426 | O00507 | |
| WEGQLVNLFARLATD | 251 | Q14997 | |
| GVISTNVLIEDLLNW | 111 | Q96BW9 | |
| LVGFIADLNIDSWLI | 316 | Q8IUH5 | |
| LGLLSQEGEAATQQW | 1271 | Q5SXM2 | |
| QAQRLTEWLQLSGFE | 21 | P0C7M3 | |
| EIRSAWQALEQGQLA | 766 | Q9H7P9 | |
| QQLISGSLDNIVKLW | 356 | Q9GZL7 | |
| LAWTDGNQVVLTDLR | 26 | Q9H6R7 | |
| ALVSQELQRADLGLW | 1636 | Q14669 | |
| LEALLAQWSQAQLSD | 476 | Q5TAA0 | |
| GQICLWDLSVELQIN | 41 | Q9Y4E6 | |
| GWNECEQTVALLSLL | 16 | Q9UPU9 | |
| QISLLSREWGFAEQL | 886 | O75385 | |
| LEGDQRWINTVAQAL | 166 | Q9H267 | |
| GLLDETQDAQWQRAL | 856 | Q6PFW1 | |
| LLRQLVQEALQWEAG | 531 | Q9BYX2 | |
| QVDEANLLTWQGLIV | 26 | P68036 | |
| LIAAGTLNGVIILWN | 661 | B1ANS9 | |
| VVLSLIAAAWAEEQN | 6 | Q92876 | |
| VQLTAIEILAWGLRN | 1301 | Q9NZM1 |